| 1/30/2026 | DD | Luminar Technologies reports $55 million net loss for December
|
| 1/30/2026 | DD | Luminar secures court OK to sell LSI assets to Quantum Computing
|
| 1/30/2026 | DD | Luminar receives final court approval to access cash collateral
|
| 1/28/2026 | DD | Luminar secures court approval to sell LiDAR business to MicroVision
|
| 1/15/2026 | DD | Luminar names stalking horse as successful bidder for LSI assets
|
| 1/14/2026 | DD | Luminar Technologies extends sale timeline for LiDAR business
|
| 1/12/2026 | DD | Luminar names Quantum Computing stalking horse for LiDAR business
|
| 1/9/2026 | DD | Luminar extends bid deadline for LiDAR assets to Jan. 12
|
| 1/5/2026 | DD | Luminar says former CEO refusing to cooperate with investigation
|
| 12/31/2025 | DD | Luminar files plan, receives approval of bid procedures for assets
|
| 12/30/2025 | DD | Luminar Technologies has creditors committee added to case
|
| 12/19/2025 | BKCVDDEMHY | Prospect News reports three new defaults for Dec. 11-Dec. 17
|
| 12/17/2025 | DD | Luminar Technologies receives interim OK of cash collateral use
|
| 12/15/2025 | CVDDHY | Luminar files Chapter 11, eyes $110 million sale to Quantum Computing
|
| 12/8/2025 | CVDDHY | Luminar enters fifth forbearance agreement, extends to Dec. 14
|
| 11/26/2025 | CVDDHY | Luminar enters fourth forbearance agreement, extends to Dec. 2
|
| 11/13/2025 | CVDDHY | Luminar enters third forbearance agreement, extends to Nov. 24
|
| 11/7/2025 | CVDDHY | Luminar enters second forbearance agreement, extends to Nov. 12
|
| 10/31/2025 | CVDDHYLM | Luminar enters forbearance, skips Oct. 15 interest payment
|
| 5/23/2025 | CV | Market Commentary: Luminar exchanges notes; Mirion gains outright; Centrus Energy goes nuclear
|
| 5/23/2025 | CV | Market Commentary: Morning Commentary: Luminar exchanges notes; convertibles secondary at a crawl
|
| 5/23/2025 | CVLM | Luminar to exchange $50 million 1.25% convertibles for stock, cash
|
| 3/24/2025 | CVLM | Luminar to exchange $18.2 million 1.25% convertibles for stock, cash
|
| 5/16/2024 | SP | New Issue: JPMorgan prices $800,000 51% autocallable contingent interest notes linked to Luminar
|
| 2/11/2024 | SP | New Issue: Morgan Stanley prices $500,000 39% contingent income autocallables tied to Luminar
|
| 7/20/2023 | CV | Market Commentary: Morning Commentary: Tesla brings competition to software market; Luminar in focus
|
| 7/19/2023 | CV | Market Commentary: Carvana drops following exchange offer; Luminar convertible notes up; BridgeBio better
|
| 7/19/2023 | CV | Market Commentary: Morning Commentary: Carvana in focus on exchange offer; Luminar convertible notes up
|
| 9/22/2022 | CV | Market Commentary: Convertibles drift lower; Live Nation down outright, mixed on hedge; Expedia weakens
|
| 1/20/2022 | CV | Market Commentary: Peloton convertible notes in focus as stock tanks; SoFi, Luminar skyrocket outright
|
| 1/20/2022 | CV | Market Commentary: Morning Commentary: SoFi Technologies, Luminar convertibles top par in early trading
|
| 12/23/2021 | CV | Market Commentary: BeautyHealth convertibles rebound outright; Fortive active; Luminar hits new heights
|
| 12/23/2021 | CV | Luminar’s remaining greenshoe exercised, ups 1.25% convertible notes to $625 million
|
| 12/22/2021 | CV | Market Commentary: Western Digital convertibles active; Luminar gains; Confluent, Norwegian Cruise improve
|
| 12/21/2021 | CV | Market Commentary: Convertibles secondary bid up; Expedia, Southwest Airlines eyed; Bilibili, Luminar gain
|
| 12/17/2021 | CV | Luminar partial greenshoe lifts 1.25% convertibles to $600 million
|
| 12/16/2021 | CV | Market Commentary: Danimer convertibles offering sees pushback; Global Blood gains; Luminar, Ford improve
|
| 12/15/2021 | CV | Market Commentary: Global Blood rips on debut as hedge funds miss out; Luminar crumbles; Vroom hits new low
|
| 12/15/2021 | CV | Market Commentary: Morning Commentary: Global Blood Therapeutics convertibles rip on debut; Luminar crumbles
|
| 12/15/2021 | CV | New Issue: Luminar prices upsized $550 million five-year convertibles to yield 1.25%, up 32.5%
|
| 12/14/2021 | CV | Market Commentary: Luminar, Global Blood Therapeutics convertible offerings eyed; Everbridge improves
|
| 12/14/2021 | CV | Market Commentary: Morning Commentary: Luminar, Global Blood Therapeutics convertible offerings in focus
|
| 12/14/2021 | CV | Luminar talks $500 million five-year convertible notes to yield 0.75%-1.25%, up 32.5%-37.5%
|
| 10/8/2021 | SP | New Issue: HSBC sells $1 million contingent income barrier autocalls on Luminar, Tesla
|
